Clinical Trials Browser

Terminated × Lymphoma, Mantle-Cell × ibritumomab tiuxetan × Clear all

NCT01497275 2015-07-15

Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma

Phase 2 Terminated

5 enrolled 8 charts

Lymphoma, Mantle-Cell